{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:39:48Z","timestamp":1787585988344,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jaad.2015.01.029","type":"journal-article","created":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T01:46:51Z","timestamp":1425692811000},"page":"834-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Infectious complications in bullous pemphigoid: An analysis of risk factors"],"prefix":"10.1016","volume":"72","author":[{"given":"Yee Wei","family":"Phoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.C.","family":"Fook-Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamotharampillai","family":"Thirumoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu Ming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-5810","authenticated-orcid":false,"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.01.029_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib3","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2015.01.029_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","article-title":"Mortality rate of bullous pemphigoid in a US medical center","volume":"122","author":"Colbert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","article-title":"Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States","volume":"59","author":"Parker","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroid and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","article-title":"Mortality of bullous pemphigoid in Switzerland: a prospective study","volume":"165","author":"Cort\u00e9s","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/jdv.12065","article-title":"Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical center","volume":"28","author":"Gual","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.01.029_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.12806","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients","volume":"170","author":"Cai","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2012.1906","article-title":"Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study","volume":"23","author":"Zhang","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archdermatol.2012.2994","article-title":"Mortality of bullous pemphigoid in China","volume":"149","author":"Li","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1346-8138.12175","article-title":"Infection in autoimmune bullous diseases: a retrospective comparative study","volume":"40","author":"Lehman","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-2133.2009.09350.x","article-title":"A population-based study of acute medical conditions associated with bullous pemphigoid","volume":"161","author":"Langan","year":"2009","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.01.029_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.01.029_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000345625","article-title":"Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study","volume":"225","author":"Cortes","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.01.029_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"BJD"},{"key":"10.1016\/j.jaad.2015.01.029_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000362717","article-title":"Assessment of Bullous Pemphigoid Disease Area Index during treatment: a prospective study of 30 patients","volume":"229","author":"Levy-Sitbon","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.01.029_bib21","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pfutze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaad.2015.01.029_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000324899","article-title":"Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months","volume":"222","author":"Ingen-Housz-Oro","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.01.029_bib24","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"10","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2015.01.029_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.annder.2010.03.015","article-title":"Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids","volume":"137","author":"Boughrara","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.01.029_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1989.tb07769.x","article-title":"Dapsone as first line therapy for bullous pemphigoid","volume":"120","author":"Venning","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archderm.1977.01640050070009","article-title":"Bullous pemphigoid responding to sulfapyridine and the sulfones","volume":"113","author":"Person","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.01.029_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1684\/ejd.2012.1717","article-title":"High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid","volume":"22","author":"Gaitanis","year":"2012","journal-title":"Eur J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:33:56Z","timestamp":1759271636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0190962215000948"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.01.029","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious complications in bullous pemphigoid: An analysis of risk factors","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}